How does adenosine control neuronal dysfunction and neurodegeneration?

RA Cunha - Journal of neurochemistry, 2016 - Wiley Online Library
The adenosine modulation system mostly operates through inhibitory A1 (A1R) and
facilitatory A2A receptors (A2AR) in the brain. The activity‐dependent release of adenosine …

Adenosine receptors: expression, function and regulation

S Sheth, R Brito, D Mukherjea, LP Rybak… - International journal of …, 2014 - mdpi.com
Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which
mediate the physiological actions of adenosine. To date, four AR subtypes have been …

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update

BB Fredholm, AP IJzerman, KA Jacobson… - Pharmacological …, 2011 - ASPET
In the 10 years since our previous International Union of Basic and Clinical Pharmacology
report on the nomenclature and classification of adenosine receptors, no developments …

Adenosine/A2B receptor signaling ameliorates the effects of aging and counteracts obesity

T Gnad, G Navarro, M Lahesmaa, L Reverte-Salisa… - Cell metabolism, 2020 - cell.com
The combination of aging populations with the obesity pandemic results in an alarming rise
in non-communicable diseases. Here, we show that the enigmatic adenosine A2B receptor …

Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling

MJ Lohse, S Nuber, C Hoffmann - Pharmacological reviews, 2012 - ASPET
Fluorescence and bioluminescence resonance energy transfer (FRET and BRET)
techniques allow the sensitive monitoring of distances between two labels at the nanometer …

Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade

RA Cunha - Purinergic signalling, 2005 - Springer
Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …

Targeting adenosine A2A receptors in Parkinson's disease

MA Schwarzschild, L Agnati, K Fuxe, JF Chen… - Trends in …, 2006 - cell.com
The adenosine A 2A receptor has emerged as an attractive non-dopaminergic target in the
pursuit of improved therapy for Parkinson's disease (PD), based in part on its unique CNS …

A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer

JR James, MI Oliveira, AM Carmo, A Iaboni, SJ Davis - Nature methods, 2006 - nature.com
Bioluminescence resonance energy transfer (BRET), which relies on nonradiative energy
transfer between luciferase-coupled donors and GFP-coupled acceptors, is emerging as a …

Adenosine receptor–dopamine receptor interactions in the basal ganglia and their relevance for brain function

K Fuxe, S Ferré, S Genedani, R Franco, LF Agnati - Physiology & behavior, 2007 - Elsevier
The dopamine D1 and D2 receptors are major receptors in the regulation of striatal function
and striatal adenosine A1 and A2A receptors are major modulators of their signaling. The …

Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

K Fuxe, S Ferré, M Canals, M Torvinen… - Journal of molecular …, 2005 - Springer
The existence of A 2A-D 2 heteromeric complexes is based on coimmunoprecipitation
studies and on fluorescence resonance energy transfer and bioluminescence resonance …